Background: Hypertension (high blood pressure) is a common long-term health con-
| BACKG ROU N D
Shared decision making is a process by which clinicians and patients work together to make health-care choices, based on clinical evidence and the patient's informed preferences. 1 Shared decision making is viewed as an ethical imperative by health-care professional regulatory bodies 2 and is embedded in health policy in several countries, including the UK and the United States. 3, 4 It is increasingly advocated in the care of all conditions, including chronic health-care conditions such as hypertension (high blood pressure) 5 Implementing shared decision making in routine care has proven challenging, and many barriers have been identified from both patient and healthcare professional perspectives. 6, 7 Interventions to support shared decision making include those which prepare health-care teams, individual clinicians or patients before consultations (e.g patient coaching interventions, decision aids, clinician or health-care team training interventions), and those which help practitioners and patients make decisions together during consultations, notably decision aids. There is evidence from conditions other than hypertension that shared decision making can lead to more appropriate care, 8 reduce overtreatment, 9 improve health outcomes 10 and may reduce health-care treatment costs. 11 A systematic review of interventions to support the adoption of shared decision making by health professionals 12 was unable to draw conclusions about the most effective interventions for supporting health professionals' adoption of shared decision making, due to the paucity of evidence. None of the studies in that review focused on people with hypertension. A recent systematic review of randomized controlled trials, including one study that did focus on hypertension management, found that people exposed to decision aids feel more knowledgeable, clearer about their values and may make choices more in line with their values. 8 Hypertension affected 31% of the world's adult population in 2010 13 ; it increases the risk of cardiovascular conditions such as strokes and heart attacks and is the leading preventable cause of premature death worldwide. 14 Observational studies show a progressive rise in cardiovascular risk as systolic blood pressure rises above 115 mmHg. 15 Hypertension is diagnosed when a person's blood pressure (BP) exceeds a threshold, typically 140/90 mmHg. 16 Management is characterized by monitoring of blood pressure alongside other cardiovascular risk factors and the use of lifestyle measures, usually combined with antihypertensive drug treatment to reduce blood pressure below treatment thresholds. Optimal treatment targets vary and are the subject of vigorous debate. 17 Treatment is typically lifelong with adjustment and, often, intensification of antihypertensive treatment over time. Hypertension control is frequently considered suboptimal, that is it fails to reach specified treatment targets. 18 Achieving blood pressure control has the potential for improved outcomes and cost savings at the population level. 19, 20 However, from an individual patient's perspective, the potential benefits are less certain. Options to reduce blood pressure include a choice of medications and lifestyle changes. Potential benefit will vary with an individual's overall cardiovascular risk, and potential disbenefits include medication side-effects and the burden of having to take daily medication. Patients making decisions about antihypertensive drug treatment require discussions about treatment to be personalized in order for the decisions to make sense to them. 21 Shared decision making for hypertension has the potential to address this challenge, yet it is unclear how best to support shared decision making for hypertension, and the effect of shared decision making on outcomes is unknown. Given the high prevalence of hypertension and its impact on cardiovascular risk, shared decision making for hypertension may have profound impacts at both individual and public health levels.
| Objective
The main objective of this study was to determine the effectiveness of interventions, including but not limited to decision aids, to support shared decision making in hypertension. A second objective was to describe the outcomes that have been used to evaluate interventions supporting shared decision making for hypertension.
| ME THODS
The protocol for this systematic review was registered on PROSPERO (CRD42015014143). 22 
| Search strategy
We used search strategies incorporating subject heading and text word searches focused on shared decision making and hypertension (see Appendix 1 for MEDLINE searches). The search was developed in MEDLINE and adapted for subsequent databases. We searched MEDLINE, EMBASE, CINAHL, Web of Science, PsycINFO and the Cochrane library from their inception to September 2017. We identified further potentially relevant articles from forward (via Google Scholar) and backward (reference list of paper) citation tracking of included studies, applying the same inclusion criteria.
| Eligibility criteria
Following Cochrane Effective Practice and Organisation of Care (EPOC) guidance, 23 we included randomized controlled trials (RCTs), nonrandomized controlled trials, controlled before-after studies and interrupted time series studies. We included published studies reporting on interventions supporting shared decision making for adults (>18) with hypertension. Eligible comparator interventions were control or any other interventions. Interventions could be delivered in any health-care setting, either before or during consultations with any health-care professionals. We included studies describing interventions that supported shared decision making by supporting one of the two following processes of shared decision making:
supporting a patient's consideration of their options in relation to a health-care choice; or supporting a patient to consider their values and preferences in relation to a health-care choice. We included studies in which only a proportion of participants were hypertensive, if study outcomes were reported separately for the hypertensive group. We excluded studies reporting interventions unrelated to health-care decisions, for example, purely educational interventions that aimed to increase hypertension knowledge without reference to health-care choices faced by the patient. We excluded interventions that aimed to increase the involvement of patients in their own care
generally, but not in health-care decisions specifically. To develop an understanding of how interventions to support shared decision making were evaluated, we included studies regardless of the outcomes assessed. No date or language restrictions were applied.
| Reference management and study selection
EndNote X7.7 and Access 2013 were used to manage the references.
Duplicates were removed from the EndNote file. Titles and abstracts, and subsequently full texts, were screened independently by two reviewers (RJ, BP or AH); disagreements were resolved by discussion with reference to a third reviewer where necessary (KT, GF and HC).
If there was insufficient detail on potentially relevant studies within the report abstract, it was screened as full text. Reasons for exclusions of full-text reports were documented.
We scrutinized the text and reference lists of relevant systematic reviews for potentially eligible studies. Conference abstracts and relevant study protocols were followed up either by contact with the author where possible or by searching for subsequent publications in PubMed.
| Data extraction and risk of bias
Data were extracted into a custom-designed Figure 2 .
| Data synthesis
For data pooling, where outcomes were assessed using different measures, we planned to calculate standardized mean differences (SMDs). Meta-analysis was planned if there were at least three studies with comparable interventions and outcomes at low risk of bias.
If meta-analysis was appropriate, we planned to assess heterogeneity amongst studies using the I 2 statistic. Analyses were carried out using Stata version 14.1.
24
As meta-analysis did not prove possible, we present a narrative synthesis of the studies. 25 The included studies are summarized in the text, in a table of study characteristics and in a risk of bias summary table. The outcomes reported by included studies, grouped by type of intervention, are reported in Figure 3 . Outcomes reported by at least three of the included studies are compared across the studies in forest plots and in the text.
| RE SULTS
Searches were run in December 2014 and updated in September 2017. A total of 6424 unique articles were screened, of which 91
full-text articles were assessed, and 11 reports of 6 studies were included in the review ( Figure 1 ).
26-34

| Included studies
Eleven papers were published from six studies, all based in primary care (Table 1) . Five studies reported randomized controlled trials, 26, 27, 29, 30 of which two were cluster randomized. 29, 30 The remaining study was a nonrandomized controlled study. 
| Profile of patients
The range of mean age of study participants was 58.5-64.5 years, and the range of female participants was 32.5%-66.0%. In five studies, all recruited patients had hypertension. [26] [27] [28] [29] 34 In the remaining study, 30 only a proportion of participants were hypertensive, although all had raised cardiovascular risk. Only results relating to the hypertensive patients within this study are included in this review. 
| Profile of interventions
The interventions were heterogeneous in their content and often multicomponent ( 31 In the final study, 26 the intervention was a leaflet distributed to patients with hypertension and hypothesized to lead to greater involvement of patients in their health-care choices, with the potential for improving on blood pressure control.
In four studies, 26, 28, 29, 34 interventions supported the involvement of patients with established hypertension, without specifying which treatment choices were being supported. In one study, 
| Risk of bias
Risk of bias assessment is reported in Figures 2 and 3 . One nonrandomized controlled study was included in the review and was at high risk of bias for most domains. Two of the RCTs were at uncertain or high risk of bias for the majority of domains. 26, 34 Three RCTs were at low risk for most domains. 27, 29, 30 However, the two RCTs reporting shared decision making were at uncertain risk of bias for this outcome because of the impossibility of blinding for, as well as the subjectivity of, this outcome.
| Outcomes
The included studies assessed a range of outcome measures.
Outcomes reported, by intervention type and risk of bias, are shown in Figure 3 . Four studies reported a measure of shared decision making. 27, 28, 32, 34 Clinical outcomes reported were as follows: blood pressure (five studies), 26, 28, 29, 31, 34 Was knowledge of allocated intervention adequately prevented during the study?
Was the study adequately protected against contamination?
Was the study free from selective outcome reporting?
Was the study free from other risks of bias? Overall assessment
Hypertension knowledge 31 diagnosis of diabetes, left ventricular hypertrophy and lipid profile (all reported in a single study). 31 Behavioural utcomes were medication adherence (three studies), 29, 31, 34 smoking status (one study) 31 and intention to start treatment (one study). 31 Anxiety was the only psychological outcome reported (one study). 27 Cognitive outcomes were hypertension knowledge (four studies) [26] [27] [28] [29] and intention to start treatment (one study). 27 Only one study reported a measure of health-care use. 30 Other outcomes included health-related quality of life (one study) 28 and clinician communication (one study). 33 Here, we discuss our primary outcome (shared decision making), and the outcomes reported in at least three of the included studies (blood pressure, hypertension knowledge and medication adherence). The decision to limit our discussion to the most commonly reported one was a post hoc decision, as detailed reporting of all of the outcomes reported was not practical. All outcomes are reported in Table 2 . None of the outcomes met our prespecified criteria for meta-analysis of at least three studies with comparable interventions and outcomes at low risk of bias; therefore, we did not pool data for any outcome.
| Primary outcome: shared decision makingrisk of bias (Figure 2) and results (Table 2 and Figure 4)
The four studies measuring shared decision making 27-29 used different patient self-report measures; measures are described in Table 2 .
Shared decision making was assessed at different times, ranging from 14 days to 18 months after the intervention. In studies in which patients received an intervention, blinding patients to treatment allocation was not possible. All studies measuring shared decision making in this review were assessed as uncertain [27] [28] [29] or high risk of bias 28, 34 for this outcome, due to inadequate prevention of treatment allocation knowledge. The SMD in change from baseline for shared decision-making measures, for studies with useable data at 12 months, is shown in Figure 3 .
Tinsel and colleagues 29 use the nine-item Shared Decision
Making Questionnaire (SDM-Q-9) 37 as a coprimary outcome for the study. The mean SDM-Q-9 score decreased in both intervention and control groups. The difference, between intervention and control, in mean change from baseline (to approximately 18 months) was 3.1182, 97.5% CI −2.3730; 8.6093, P = 0.2029.
Deinzer 28 reported two shared decision-making measures: the Autonomy Preference Index (API) 38 and a modified version of the COMRADE scale. 39 In this study with a high risk of bias, the authors report that at 1 year there was no change in API from baseline in either the intervention or control group, although API scores were not reported (P = 0.83 for the comparison). A comparison between the COMRADE scores in the intervention and control groups was not reported.
The primary outcome in the study by Montgomery and colleagues 27 was the Decisional Conflict Scale (DCS), a 16-item patient self-report scale. 40 The DCS was measured after receipt of the intervention (mean 14 days after randomization). The adjusted difference in mean DCS score (decision analysis vs no decision analysis) was −9.4 (95% CI −13.0 to −5.8), P < 0.001.
F I G U R E 3
Outcomes reported in included studies, by intervention type and risk of bias. RED = high risk of bias; ORANGE = uncertain risk of bias; GREEN = low risk of bias; HCP = health-care professional. *Outcomes reported for the study by Denig are only those reported for the hypertensive subgroup within the study 
| Secondary outcomes-risk of bias (Figure 2) and results (Table 2 and Figures 5 and 6)
Five studies evaluated the effect of the intervention on blood pressure 26, 28, 29, 31 (Table 2) ; two studies were at low risk of bias, and three were at high risk of bias, for this outcome 26, 28 ( Figure 2 ). Blood pressure was measured at different time points (range 6 months to 3 years). Four of the five studies (two at low risk of bias) report that there was no difference between blood pressure in the intervention and control groups; in the fifth study, intervention and control were not formally compared. The mean difference in change from baseline after 1 year in three studies with useable data is shown in Figure 5 .
Hypertension knowledge was assessed in four studies, 26, 28, 29, 31 at different time points (range 14 days to 18 months), using different scales in each study. Results were conflicting: two studies reported that the intervention increased hypertension knowledge, 26, 27 and two studies 28, 29 reported that there was no statistical evidence of a difference in hypertension knowledge between intervention and control. Two studies reported comparable scales at similar time points; SMDs for these studies are reported in Figure 6 .
Adherence was assessed in three studies 27, 29, 34 at different time points (range 6 months to 3 years) and using different patient self-report measures; two studies 29, 31, 34 were at uncertain risk, and one study 43 was at high risk for this outcome. In each of the three studies, there was no statistical evidence of a difference between intervention and control in patient-reported adherence. Reporting 
| D ISCUSS I ON
This review identified a small number of studies evaluating the effectiveness of different interventions to support shared decision making in the management of hypertension. Meta-analysis of the included studies was not undertaken because of clinical heterogeneity (differences in interventions and outcomes) and methodological heterogeneity (differences in the risk of bias of studies). We have found that there is insufficient evidence to inform which intervention should be used to support shared decision making for hypertension in routine clinical care.
We identified six studies (five randomized controlled trials 26, 27, 29, 30, 43 and one controlled study) 26 evaluating interventions to support shared decision making for hypertension. The main intervention components were training for health-care professionals (three studies), 28, 29, 34 decision aids (two studies), 27 patient coaching (one study) 34 and a patient leaflet (one study). 26 All included studies were based in primary care. No studies measuring shared decision making were at low risk of bias for this outcome. Two trials, both at uncertain risk of bias, had conflicting results: in one, a GP training intervention did not increase patient-perceived shared decision making over 18 months, 29 and in the second study, decision analysis reduced decisional conflict at 14 days. 27 Of two further studies at high risk of bias, 34 only one provided useable data Strengths of this review include the use of a comprehensive search strategy employing a range of synonyms for shared decision making.
Our definition of shared decision making builds on previous research in this area; our two core components of shared decision making were the elements that appear most frequently in conceptual definitions of shared decision making 44 and are central to the most frequently cited model of decision making. 45 To avoid missing eligible studies, we were inclusive at the title and abstract screening stage, where intervention descriptions were often sparse. No language restrictions were used, and screening was carried out in duplicate. Uncertainties about inclusion were discussed within a multidisciplinary team of GPs/health service researchers and social scientists to ensure validity of selection.
Using a narrative synthesis approach, we have been able to apply tools systematically resulting in a robust summary of the available studies, as well as highlighting where the evidence base is limited. To our knowledge, this is the first study to review interventions to support shared decision making for hypertension.
Limitations of this review include the small number of eligible studies, many of which were at uncertain or high risk of bias. The included studies described a range of interventions and evaluated a range of outcome measures, making it more challenging to summarize the data using a narrative approach. Although useful in providing an overview of the evidence available (Figure 3) , this clinical heterogeneity prevented pooling of the data. An important limitation of the included studies is that measurement of shared decision-making outcomes was biased by the lack of blinding of outcome assessment and the subjective nature of shared decision-making outcomes. The mechanisms by which interventions might achieve their outcomes were not clearly articulated within the papers. The rationale implied in several studies is that shared decision making might enhance patient's understanding and through this compliance with antihypertensive medication. This rationale is evident in the choice of hypertension knowledge and adherence as study outcomes. Explicit acknowledgement of the mechanisms by which interventions are expected to influence outcomes including shared decision making, for example through a logic model, would be helpful in interpreting study findings.
Research in conditions other than hypertension has suggested that shared decision making has the potential to improve outcomes, 10 increase appropriateness of care, 8 reduce overtreatment 9 and reduce treatment costs. 11 Given the limitations of the studies within the review, the effects of shared decision making in hypertension remain uncertain, and none of these potential benefits can be confirmed. The interventions in several of the included studies [28] [29] [30] 33 aimed to change the behaviour of clinicians in order to facilitate shared decision making. The challenges, for health professionals, in implementing shared decision making have been well described and include time constraints and the perceived lack of applicability of shared decision making to the particular clinical situation. 7 A recent review focussing on studies measuring shared decision making and patient outcomes found that shared decision making, when perceived to be happening by patients, tended to result in improved affective-cognitive outcomes, but that evidence was lacking for patient behavioural and health outcomes. 46 Consistent with this review, we found that all of our included studies that measured shared decision making used a patient-reported measure.
In the care of people with hypertension, there is a potential conflict between the aim of ensuring shared decision making occurs, and the aim of optimizing blood pressure control. Several of the included studies aimed to do both. The effect of shared decision making on clinical outcomes is important because, should it be implemented widely, it has the potential to impact on public health outcomes. 47 For example, should the consequence of shared decision making be that fewer people take antihypertensive medication, this will increase cardiovascular events. However, the rationale for shared decision making is not to improve compliance with clinical or public health priorities, and it is to achieve a decision which is congruent with the patient's personal priorities, values and beliefs. This potential conflict was not discussed in the study reports.
| CON CLUS ION
Hypertension is a long-term condition in which patients and their clinicians frequently face choices about starting or modifying hypertension treatment. Shared decision making is increasingly advocated for all health-care choices, including those taken in the care of long-term conditions. 5 Decision aids continue to proliferate, 48 and front-line clinicians have called for more decision support interventions to help them to share decisions with patients. In this study, we have shown that there is little evidence to guide a choice of interventions to support shared decision making for hypertension.
There is insufficient evidence to recommend how to support shared decision making for patients with hypertension in routine clinical care. Further studies are needed to develop and test interventions able to support patients to share decisions with their clinicians and which can be incorporated into routine care. Future research should make explicit the underpinning theory of the intervention's mechanism of effect and should consider using observerrated measures of shared decision making.
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